These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36715769)

  • 1. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.
    Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y
    Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.
    Kinoshita M; Kubo S; Nakanuma Y; Sato Y; Takemura S; Tanaka S; Hamano G; Ito T; Terajima H; Yamada T; Nakamori S; Arimoto A; Fujikawa M; Sugawara Y; Yamamoto T; Abue M; Nakagawa K; Unno M; Mizuguchi T; Takenaka K; Shirabe K; Shibata T
    J Hepatobiliary Pancreat Sci; 2016 Feb; 23(2):92-101. PubMed ID: 26580863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
    Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
    Kim JR; Jang KT; Jang JY
    Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
    Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
    PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
    Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
    Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
    Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
    Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Type 1 and Type 2 Intraductal Papillary Neoplasms of the Bile Duct.
    Huang XH; Chen TX; Liu HL; Huang MW
    Curr Med Sci; 2024 Jun; 44(3):485-493. PubMed ID: 38748369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases.
    Onoe S; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Watanabe N; Otsuka S; Nakamura S; Shimoyama Y; Nagino M
    HPB (Oxford); 2021 Oct; 23(10):1525-1532. PubMed ID: 33832834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.
    Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
    Komori T; Inoue D; Zen Y; Yoneda N; Kitao A; Kozaka K; Yokka A; Toshima F; Matsubara T; Kobayashi S; Gabata T
    Eur Radiol; 2019 Jun; 29(6):3132-3140. PubMed ID: 30519930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
    Chang XY; Li J; Ren XY; Zhou WX; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic characterization of precursors and cholangiocarcinoma referring to peribiliary capillary plexus: a new pathologic approach to bile duct neoplasm.
    Nakanuma Y; Kakuda Y; Canh HN; Sasaki M; Harada K; Sugino T
    Virchows Arch; 2024 Aug; 485(2):257-268. PubMed ID: 39008118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.